Bevacizumab for Breast Cancer Hotly Debated
Monday 6 September 2010
The use of bevacizumab (Avastin, Roche) in the treatment of breast cancer has hit the headlines again. Many media outlets in the United Stateshave been discussing the fact that US Food and Drug Administration (FDA) approval for the use of bevacizumab in the treatment of metastatic breast cancer could be revoked.
>> http://www.medscape.com/viewarticle/727239?sssdmh=dm1.633176&src=nldne&uac=152441AJ
European Oncology Nursing SocietyAvenue E. Mounier 83
B-1200 Brussels
Belgium
Tel: +32 (0)2 779 9923
Fax: +32 (0)2 779 9937
eons.secretariat@cancernurse.eu